These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34175461)

  • 1. The Weighty Issue of Treating Obesity in Patients With Nonalcoholic Fatty Liver Disease.
    Adams LA
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):505-507. PubMed ID: 34175461
    [No Abstract]   [Full Text] [Related]  

  • 2. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intersection of nonalcoholic fatty liver disease and obesity.
    Woo Baidal JA; Lavine JE
    Sci Transl Med; 2016 Jan; 8(323):323rv1. PubMed ID: 26819197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and Nonalcoholic Fatty Liver Disease.
    Chaney A
    Nurs Clin North Am; 2021 Dec; 56(4):543-552. PubMed ID: 34749893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption].
    Sun FR; Wang BY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):212-216. PubMed ID: 32306654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease.
    Patel SS; Siddiqui MS
    Drugs; 2019 Jan; 79(1):75-84. PubMed ID: 30588564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction.
    Mathews SE; Kumar RB; Shukla AP
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):315-320. PubMed ID: 30074500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.
    Linden MA; Lopez KT; Fletcher JA; Morris EM; Meers GM; Siddique S; Laughlin MH; Sowers JR; Thyfault JP; Ibdah JA; Rector RS
    Appl Physiol Nutr Metab; 2015 Oct; 40(10):1038-47. PubMed ID: 26394261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity.
    Rachakonda V; Wills R; DeLany JP; Kershaw EE; Behari J
    Obesity (Silver Spring); 2017 Aug; 25(8):1360-1368. PubMed ID: 28605159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: VII. Routine treatment: when referring to specialists].
    Sumida Y; Seko Y; Itoh Y
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):56-61. PubMed ID: 27266044
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.
    Cui H; Zhang X
    J Pediatr Endocrinol Metab; 2020 May; 33(5):579-584. PubMed ID: 32187014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.
    Bril F; Cusi K
    Diabetes Care; 2017 Mar; 40(3):419-430. PubMed ID: 28223446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review.
    Caro-Sabido EA; Larrosa-Haro A
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):185-194. PubMed ID: 31101468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.